Loading…
Conexeu Sciences Inc. is projected to decline to $7.47 by 2027, a -10% move from its current price of $8.31. Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $7.77 | $8.31 | $8.89 | +0.02% |
| Aug 4 | $7.56 | $8.31 | $9.14 | +0.05% |
| Aug 5 | $7.40 | $8.32 | $9.34 | +0.07% |
| Aug 6 | $7.27 | $8.32 | $9.51 | +0.09% |
| Aug 7 | $7.16 | $8.32 | $9.67 | +0.12% |
| Aug 8 | $7.06 | $8.32 | $9.81 | +0.14% |
| Aug 9 | $6.97 | $8.32 | $9.94 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.97 | $8.32 | $9.94 | +0.16% |
| Week 2 | $6.48 | $8.34 | $10.72 | +0.32% |
| Week 3 | $6.14 | $8.35 | $11.36 | +0.49% |
| Week 4 | $5.86 | $8.36 | $11.93 | +0.65% |
| Week 5 | $5.63 | $8.38 | $12.46 | +0.81% |
| Week 6 | $5.43 | $8.39 | $12.97 | +0.98% |
| Week 7 | $5.25 | $8.40 | $13.45 | +1.14% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CNXU is the ticker for Conexeu Sciences Inc., a healthcare company focused on collagen-based regenerative tissue scaffold products for medical aesthetics and tissue repair. It develops patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis.
The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. It was founded in 2022 and is based in Reno, Nevada.
CNXU is currently priced at $8.83 and has a market cap of $236.28M. It ranks 3,475th in market capitalization, highlighting its position in the small-cap segment of the market. The price outlook is mixed over the forecast horizon, with near-term stability and notable long-term upside suggested by the year-by-year projections.
In the long run, the model points to a path of higher potential, notably in the 2040s and beyond, albeit with substantial volatility along the way.
A major floor 50.0% below — a decisive break under it would weaken the trend.
The nearest floor, 7.6% below — buyers have tended to step in here.
The nearest ceiling, 59.8% above — a clean break opens room to run.
A major ceiling 102.8% above — clearing it would confirm fresh momentum.
Key CNXU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CNXU market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.10 | Buy | $8.38 | Sell |
| MA 10 | $8.61 | Sell | $8.68 | Sell |
| MA 20 | $9.40 | Sell | $9.34 | Sell |
| MA 50 | — | Neutral | — | Neutral |
| MA 100 | — | Neutral | — | Neutral |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.92 | Neutral |
| Stoch RSI (14) | 37.48 | Neutral |
| CCI (20) | -88.98 | Neutral |
| Williams %R (14) | -82.00 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -25.67 | Sell |
| Bollinger %B (20,2) | 0.22 | Neutral |
| Stochastic %K (14) | 18.00 | Buy |
| TRIX (15) | -1.13 | Sell |
| Awesome (5,34) | -2.04 | Sell |
| Ultimate (7,14,28) | 36.46 | Neutral |
| Momentum (10) | -1.52 | Sell |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 8.06 | Buy |
| ADX (14) | 14.10 | Neutral |
| ATR (14) | 0.65 | Info |
The near-term technical picture is BEARISH, with an RSI of 40. The absence of explicit SMA50/SM A200 values leaves the trend ambiguous on moving-average signals, but the price action is constrained by defined support and resistance levels. The key support is at $7.68 and the key resistance is at $13.28, framing a broad 30-day risk/reward window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.68 | $8.31 | $11.92 | 0% | Neutral | |
| $4.91 | $7.47 | $12.29 | -10% | Neutral | |
| $3.98 | $6.72 | $12.06 | -19% | Bearish | |
| $3.67 | $6.79 | $13.01 | -18% | Bearish | |
| $3.05 | $6.17 | $12.45 | -26% | Bearish | |
| $3.47 | $7.63 | $16.11 | -8% | Neutral | |
| $4.20 | $9.34 | $20.49 | +12% | Neutral | |
| $4.15 | $9.23 | $20.96 | +11% | Neutral | |
| $4.57 | $10.16 | $23.38 | +22% | Bullish | |
| $3.88 | $8.62 | $19.84 | +4% | Neutral | |
| $6.18 | $13.74 | $31.61 | +65% | Bullish | |
| $7.61 | $16.92 | $38.91 | +104% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $7.68 | $8.31 | $10.64 | +0.00% |
| September 2026 | $6.49 | $8.13 | $10.77 | -2.16% |
| October 2026 | $6.63 | $8.49 | $11.57 | +4.38% |
| November 2026 | $6.75 | $8.80 | $12.27 | +3.70% |
| December 2026 | $6.32 | $8.37 | $11.92 | -4.86% |
Click any year to see its month-by-month CNXU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CNXU is projected to trade between $7.68 and $11.92, averaging $8.31 — a potential gain of 0% from today's $8.31. A consolidation phase looks the most probable path here.
Conexeu Sciences Inc.'s 2027 outlook centres on $7.47, within a $4.91 to $12.29 range. That is -10% versus the projected 2026 average. That marks a -10% change versus current levels. Price action looks broadly range-bound.
By 2028, CNXU could reach as high as $12.06, with a base case around $6.72 and support toward $3.98 — roughly -19% from $8.31. Expect choppier, lower action through this leg of the cycle.
Expect CNXU to range from $3.67 to $13.01 through 2029. The $6.79 average target implies a -18% move from current prices. That is up +1% on the projected 2028 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The CNXU price prediction for 2030 points to an average of $6.17 (low $3.05, high $12.45) — a potential decline of -26% on today's $8.31. Expect choppier, lower action through this leg of the cycle.
In 2031, CNXU is projected to trade between $3.47 and $16.11, averaging $7.63 — a potential decline of -8% from today's $8.31. That is up +24% on the projected 2030 average. Price action looks broadly range-bound.
Conexeu Sciences Inc.'s 2032 outlook centres on $9.34, within a $4.20 to $20.49 range. That is up +22% on the projected 2031 average. That marks a +12% change versus current levels. A consolidation phase looks the most probable path here.
By 2033, CNXU could reach as high as $20.96, with a base case around $9.23 and support toward $4.15 — roughly +11% from $8.31. Price action looks broadly range-bound.
Expect CNXU to range from $4.57 to $23.38 through 2034. The $10.16 average target implies a +22% move from current prices. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CNXU price prediction for 2035 points to an average of $8.62 (low $3.88, high $19.84) — a potential gain of +4% on today's $8.31. Price action looks broadly range-bound.
In 2040, CNXU is projected to trade between $6.18 and $31.61, averaging $13.74 — a potential gain of +65% from today's $8.31. That is up +59% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Conexeu Sciences Inc.'s 2050 outlook centres on $16.92, within a $7.61 to $38.91 range. That is up +23% on the projected 2040 average. That marks a +104% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CNXU today (≈ 120.336943 CNXU) could be worth
$2,035.96
+$1,035.96 (+104%) by 2050 · US Dollar
Based on the average projected CNXU price of $16.92 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CNXUwould be worth at today's price.
$1,000 invested in CNXU on May 21, 2026 (≈ 76.511096 CNXU) would be worth
$635.81
-$364.19 (-36.4%) today · 0.64× · US Dollar
Based on a CNXU entry price of $13.07 vs. today's $8.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.57 | $969.66 | -3.0% |
| 1 month ago | $10.26 | $809.94 | -19.0% |
| All time ago | $13.07 | $635.81 | -36.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CNXU forecast.
$17.00 is within our bullish range by 2032, but above the base case.
Implied market cap at $17.00: $454.89M
The multi-year forecast shows a decline through 2030, with the 2030 average price at $6.60 and a max of $13.31, implying a -25.3% ROI and a BEARISH sentiment for that year. The sequence into 2037-2039 remains mixed, with 2032 through 2034 turning neutral to mildly bullish as averages rise toward and above the $9–$11 range and max prices climbing up to $24.81. By 2040, the average price is forecast at $14.61 with a 65.5% ROI and a BULLISH sentiment, and by 2050 the average price is $17.88 with a 102.5% ROI and a BULLISH sentiment.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $6.60, with a minimum of $3.26 and a maximum of $13.31, representing a -25.3% ROI and a BEARISH sentiment.
Forecasts indicate near-term volatility with a negative ROI through 2030, but longer-term upside is suggested, including a 65.5% ROI by 2040 and a 102.5% ROI by 2050, acknowledging the inherent uncertainty and risk.
Yes. The forecast max prices exceed $20 in multiple years: $22.38 in 2033, $24.81 in 2034, $33.61 in 2040, and $41.13 in 2050.
Current price is $8.83 and market cap is $236.28M. The stock ranks 3,475th in market capitalization.
The 30-day picture is BEARISH with RSI(14) of 40. Support is at $7.68 and resistance at $13.28, and the 30-day price range spans from $5.63 to $13.86.
Conexeu Sciences Inc. Community Discussion
0Share your Conexeu Sciences Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.